Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, 15 York St, LCI 1003, New Haven, CT, 06510, USA.
Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Neurocrit Care. 2017 Dec;27(3):326-333. doi: 10.1007/s12028-017-0425-4.
As survival rates have increased for intracerebral hemorrhage (ICH) patients, there is limited information regarding recovery beyond 3-6 months. This study was conducted to examine recovery curves using the modified Rankin Scale (mRS) and Barthel Index (BI) up to 12 months post-injury.
We prospectively enrolled 173 patients admitted with ICH who were subsequently evaluated using the mRS and BI at discharge as well as 3, 6, and 12 months. Repeated measures nonparametric testing was conducted to assess functional trajectories across time.
The mRS scores showed significant improvement between discharge (median 4) and 3 (median 4), 6 (median 4), and 12 months (median 3) (p values <0.001). However, the mRS scores did not differ between follow-up time-points (i.e., 3-6, 6-12 months). There was significant improvement in scores using the BI (p values <0.001), showing improvement between discharge (mean 43.0) and 3 (mean 73.0), 6 (mean 78.2), and 12 months (mean 83.4). Additionally, there were differences in the BI between 3 and 12 months (p = 0.013), as well as between 6 and 12 months (p = 0.025).
The BI may be a more sensitive measure of long-term recovery post-injury than the mRS, which shows minimal improvement for some survivors after 3 months. BI scores indicate survivors continually improve till 12 months post-injury. These results may have implications for the prognostication of ICH and design of clinical trial outcome measures.
随着脑出血(ICH)患者的生存率提高,关于发病 3-6 个月后恢复情况的信息有限。本研究旨在通过改良 Rankin 量表(mRS)和 Barthel 指数(BI)评估发病 12 个月内的恢复曲线。
我们前瞻性纳入了 173 例发病后入住我院的 ICH 患者,随后在出院时及 3、6、12 个月时使用 mRS 和 BI 进行评估。采用重复测量非参数检验评估各时间点的功能轨迹。
mRS 评分在出院时(中位数 4)与 3 个月(中位数 4)、6 个月(中位数 4)和 12 个月(中位数 3)时相比均有显著改善(p 值均<0.001)。然而,各随访时间点之间的 mRS 评分无差异(即 3-6 个月、6-12 个月)。BI 评分显著改善(p 值均<0.001),表现为出院时(均值 43.0)与 3 个月(均值 73.0)、6 个月(均值 78.2)和 12 个月(均值 83.4)时相比。此外,BI 评分在 3 个月与 12 个月之间(p=0.013)和 6 个月与 12 个月之间(p=0.025)有差异。
BI 可能是比 mRS 更敏感的损伤后长期恢复评估指标,mRS 在发病 3 个月后,部分幸存者的改善程度很小。BI 评分表明幸存者持续改善,直至发病后 12 个月。这些结果可能对 ICH 的预后和临床试验结局指标的设计有意义。